Compare INVA & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVA | BCAT |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2000 | N/A |
| Metric | INVA | BCAT |
|---|---|---|
| Price | $23.32 | $14.38 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | 541.3K | ★ 704.5K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.38% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 3.30 | 1.43 |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | ★ $6.98 | $10.09 |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $12.99 |
| 52 Week High | $25.15 | $15.41 |
| Indicator | INVA | BCAT |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 46.71 |
| Support Level | $20.56 | $13.77 |
| Resistance Level | $25.15 | $14.92 |
| Average True Range (ATR) | 0.53 | 0.20 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 88.04 | 60.70 |
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.